Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

January 13, 2023

Conditions
Cognitive FunctionHypercholesterolemiaQuality of Life
Interventions
DRUG

PCSK9 inhibitor

Patients are included after PCSK9 inhibitors prescription , at the first dispensation

Trial Locations (12)

15706

Complejo Hospitalario Universitario de A Coruña, A Coruña

Unknown

Hospital de Virxen da Xunqueira de Cee, Cee

Hospital Arquiteto Marcide de Ferrol, Ferrol

Hospital del Barbanza, Ribeira

Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela

Hospital Público da Mariña de Burela, Burela de Cabo

Hospital de Monforte, Monforte de Lemos

Hospital do Barco de Valdeorras, O Barco de Valdeorras

Hospital Alvaro Cunqueiro de Vigo, Vigo

Hospital Lucus-Augusti de Lugo, Lugo

Complejo Hospitalario Universitario de Ourense, Ourense

Complexo Hospitalario Universitario de Pontevedra, Pontevedra

All Listed Sponsors
lead

Jose Seijas Amigo

OTHER

NCT04319081 - Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors | Biotech Hunter | Biotech Hunter